Largest neurology conference in the world starts today
The 67th American Academy of Neurology Annual Meeting officially begins today here in beautiful Washington, D.C. Last year’s meeting in Philadelphia broke attendance…
Research Decoder: The Blood-Brain Barrier
While reading about multiple sclerosis, you may have come across the blood-brain barrier and wondered what it’s all about. Many people think of…
Research Decoder: Remyelination versus Neuroprotection
Two words that I often see used interchangeably are remyelination and neuroprotection. Both processes are part of the body’s innate repair and damage…
Research Decoder: Negative Results
In scientific research, negative results can get a bad rap. What exactly do I mean when I say “negative results”? At its core,…
Action to end MS: Part II
Developing effective therapies for progressive multiple sclerosis, a debilitating form of MS that has eluded successful treatment breakthroughs, represents one of the greatest…
The International Progressive MS Alliance scientific meeting: Connecting to end Progressive MS
Last week, I set out for the historic city of Boston to attend the second scientific meeting of the International Progressive Multiple Sclerosis…
Action to end MS: Part I
Two questions I often hear from people living with multiple sclerosis are “Why does research take so long ?” and “How close are…
Research Decoder: Risk Factors
Although there is no single cause for multiple sclerosis, one priority in research is to identify different risk factors associated with MS. A…
Can drinking coffee protect against MS?
I’ll be the first to admit that I can’t start the day without a nice, strong cup o’ joe (or two). Some interesting…
Research Decoder: Clinical Trials
There’s a lot of buzz in the world of research and in the media about clinical trials. Indeed, just a few weeks ago…